Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on July 29, 2026

Jul. 29, 2026

MAVERICK BRANDS RANKS AMONG TOP U.S. CROWDFUNDING FIRMS, LAUNCHES REPUBLICAN RED WINERY RAISE

Indeterminate EIN Presswire

Jul. 29, 2026

Quadrant Nuclear and Parsons Announce Strategic Partnership to Advance U.S. Nuclear Fuel Cycle Infrastructure

Indeterminate EIN Presswire

Jul. 29, 2026

Sitestream and The Village of Bratenahl, Ohio to Advance Traffic Safety Through Manually Operated Speed Enforcement

Indeterminate EIN Presswire

Jul. 29, 2026

OnPage Recognized in the Gartner® Hype Cycle™ for ITSM, 2026

Indeterminate EIN Presswire

Jul. 29, 2026

NVIDIA Sets Conference Call for Second-Quarter Financial Results

Indeterminate GlobeNewswire

Jul. 29, 2026

TransAlta Declares Dividends

Indeterminate GlobeNewswire

Jul. 29, 2026

Clip Money Inc. Announces Commercial Partnership

Indeterminate GlobeNewswire

Jul. 29, 2026

Big Digital Energy to Release Second Quarter 2026 Results August 12th

Indeterminate GlobeNewswire

Jul. 29, 2026

Result of General Meeting

Indeterminate GlobeNewswire

Jul. 29, 2026

Europäische Kommission genehmigt Marktzulassung des an XFG angepassten COVID-19-Impfstoffs von Pfizer und BioNTech in der Europäischen Union

Indeterminate GlobeNewswire

Jul. 29, 2026

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Indeterminate GlobeNewswire

Jul. 29, 2026

Onco360® Has Been Selected as a National Pharmacy Partner for VEPPANU™ (vepdegestrant)

Indeterminate GlobeNewswire

Jul. 29, 2026

Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Jul. 29, 2026

Smartcat launches the Content Update Coworker to close the market adaptation gap in global learning content

Indeterminate GlobeNewswire

Jul. 29, 2026

Bel Reports Second Quarter and First Half 2026 Results

Indeterminate GlobeNewswire

Jul. 29, 2026

Revolution Medicines to Report Financial Results for Second Quarter 2026 After Market Close on August 5, 2026

Indeterminate GlobeNewswire

Jul. 29, 2026

Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026

Indeterminate GlobeNewswire

Jul. 29, 2026

TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

Jul. 29, 2026

Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 29, 2026

Climb Global Solutions Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire